TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 192 filers reported holding TURNING POINT THERAPEUTICS I in Q2 2021. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,393,028 | +2.8% | 18,512 | -63.2% | 0.00% | 0.0% |
| Q1 2022 | $1,354,840 | +19.4% | 50,332 | +113.8% | 0.00% | 0.0% |
| Q4 2021 | $1,135,000 | -27.3% | 23,545 | +0.2% | 0.00% | 0.0% |
| Q3 2021 | $1,561,000 | -22.2% | 23,505 | -8.6% | 0.00% | -50.0% |
| Q2 2021 | $2,007,000 | +1.4% | 25,728 | +22.9% | 0.00% | 0.0% |
| Q1 2021 | $1,980,000 | -26.6% | 20,935 | -5.5% | 0.00% | 0.0% |
| Q4 2020 | $2,699,000 | +58.4% | 22,147 | +13.6% | 0.00% | 0.0% |
| Q3 2020 | $1,704,000 | +59.6% | 19,504 | +16.8% | 0.00% | +100.0% |
| Q2 2020 | $1,068,000 | +34.7% | 16,701 | -6.0% | 0.00% | 0.0% |
| Q1 2020 | $793,000 | +172.5% | 17,764 | +280.6% | 0.00% | – |
| Q4 2019 | $291,000 | – | 4,667 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,750,000 | $260,122,000 | 5.80% |
| Burrage Capital Management LLC | 72,164 | $6,826,000 | 5.53% |
| Consonance Capital Management LP | 450,396 | $42,603,000 | 4.54% |
| MPM BioImpact LLC | 269,186 | $25,462,000 | 3.20% |
| Orbimed Advisors | 2,361,327 | $223,358,000 | 2.09% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 81,541 | $7,711,000 | 2.04% |
| SECTORAL ASSET MANAGEMENT INC | 257,879 | $24,393,000 | 1.85% |
| Nicholas Investment Partners, LP | 218,847 | $20,701,000 | 1.44% |
| Logos Global Management LP | 140,000 | $13,243,000 | 1.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 16,741 | $1,584,000 | 0.86% |